Leadership Overview
Syngene has 4 executives leading key functions including strategy, operations, information technology, and financial management.
Focused on advancing global scientific research, Syngene delivers comprehensive discovery and development services to the pharmaceutical and biotechnology sectors through a commitment to innovation and operational excellence.
Focused on advancing global scientific research, Syngene delivers comprehensive discovery and development services to the pharmaceutical and biotechnology sectors through a commitment to innovation and operational excellence.
Leadership Roles at Syngene
Siddharth Mittal - Chief Executive Officer & Managing Director
Siddharth Mittal, the Chief Executive Officer & Managing Director at Syngene, directs the overarching strategic vision for the organization. Overseeing the integration of medicinal chemistry, biology, and cGMP manufacturing, Mittal ensures alignment across all research and development service lines. This leadership role involves driving long-term growth initiatives while maintaining high standards of scientific integrity across global markets. By fostering collaboration between internal research teams and international pharmaceutical partners, Siddharth Mittal secures the company's position as a premier contract research and manufacturing organization. The Chief Executive Officer & Managing Director monitors performance metrics to optimize service delivery and operational efficiency. Through consistent focus on expanding the company's technical capabilities, Mittal supports the advancement of complex drug discovery projects. Ultimately, the Chief Executive Officer & Managing Director maintains the organization's competitive edge within the highly regulated global life sciences landscape.

Ankush Balani - Chief Financial Officer, Strategic Finance Business Finance Corporate Finance, Mergers & Acquisitions & Investor Relations ( Office)
Ankush Balani, the Chief Financial Officer, Strategic Finance Business Finance Corporate Finance, Mergers & Acquisitions & Investor Relations ( Office) at Syngene, directs the financial health and capital allocation strategies of the organization. Overseeing corporate finance, investor relations, and strategic mergers, Balani ensures that fiscal planning supports the company's long-term growth objectives. This leadership role involves managing complex financial reporting and providing insights that guide executive decision-making regarding expansion and investment. By optimizing capital structure and maintaining transparent communication with stakeholders, Ankush Balani drives sustainable financial performance. The Chief Financial Officer, Strategic Finance Business Finance Corporate Finance, Mergers & Acquisitions & Investor Relations ( Office) monitors market trends to identify opportunities for inorganic growth and strategic partnerships. Through rigorous financial oversight, Balani ensures that the organization possesses the necessary resources to fund ongoing research and manufacturing advancements. The Chief Financial Officer, Strategic Finance Business Finance Corporate Finance, Mergers & Acquisitions & Investor Relations ( Office) maintains fiscal discipline to support the company's market position.
Arvind Atignal - Chief Operating Officer
Arvind Atignal, the Chief Operating Officer at Syngene, manages the daily execution of complex research and manufacturing workflows. Overseeing the infrastructure required for custom synthesis and process R&D, Atignal ensures that all laboratory operations meet rigorous quality standards. This leadership role involves coordinating cross-functional teams to streamline project timelines and enhance productivity across the organization's facilities. By implementing scalable operational frameworks, Arvind Atignal drives efficiency in cGMP manufacturing and formulation services. The Chief Operating Officer monitors resource allocation to support the diverse needs of global clients, ensuring that technical output remains consistent with corporate objectives. Through meticulous oversight of facility management and supply chain logistics, Atignal maintains the operational stability necessary for high-stakes drug development. The Chief Operating Officer continuously refines internal processes to improve service delivery speed and reliability, directly impacting the company's ability to meet the evolving demands of the international pharmaceutical industry.
Ajit Manocha - Syngene Vice President & Chief Information Officer (Biocon Group)
Ajit Manocha, the Syngene Vice President & Chief Information Officer (Biocon Group) at Syngene, architects the digital transformation strategy to support advanced scientific research. Overseeing the implementation of secure data management systems, Manocha ensures that all research and development information remains protected and accessible for global collaboration. This leadership role involves integrating sophisticated IT infrastructure with laboratory information management systems to enhance data integrity and research accuracy. By deploying cutting-edge digital tools, Ajit Manocha drives the modernization of internal workflows, facilitating seamless communication across the organization's diverse research departments. The Syngene Vice President & Chief Information Officer (Biocon Group) manages cybersecurity protocols to safeguard intellectual property and client data. Through the strategic application of technology, Manocha supports the company's mission to accelerate drug discovery. The Syngene Vice President & Chief Information Officer (Biocon Group) continuously evaluates emerging technologies to maintain the organization's technological leadership in the contract research sector.

Explore Leadership Teams in Business Services
CTI is an innovative, international clinical research organization specializing in a full spectrum of clinical trial and consulting services, including COVID-19 research and treatment programs. The company focuses on providing high-quality services to sponsors and partners, with a commitment to reliability and expertise. CTI serves a diverse range of clients in the pharmaceutical and biotechnology sectors, particularly those involved in infectious diseases and late-phase clinical trials. Through strategic partnerships and a robust global infrastructure, CTI aims to advance medical progress and develop effective therapies.
Company Leadership JS
MM
PD
NY Creates operates the Albany NanoTech Complex, the largest non-profit semiconductor R&D facility in the United States. This state-of-the-art campus collaborates with industry leaders, academia, and international partners to advance chip technology and fabrication processes. The organization focuses on workforce development through internships and educational programs, aiming to cultivate the next generation of professionals in semiconductor manufacturing. Additionally, NY Creates engages in research initiatives and sustainability efforts to drive innovation in the high-tech sector.
Company Leadership NB
DA
MR
WB
IRISNDT is a leading independent asset integrity company that specializes in non-destructive testing (NDT), inspection, and engineering solutions. With over 70 years of experience, they provide services to various industries including petrochemical, refining, renewables, and power generation across the USA, Canada, the UK, and Australia. Their offerings include advanced NDT services, robotic inspections, and mechanical services, all aimed at ensuring safety and operational efficiency. IRISNDT is committed to delivering high-quality, reliable services while fostering ethical relationships with clients and promoting environmental stewardship.
Company Leadership
BP
GHG Corporation is a certified Service-Disabled Veteran Owned Small Business that specializes in engineering and IT services. They offer a wide range of services including safety and mission assurance, hardware development, analysis, testing, evaluation, and space operations. Their clients include both government and commercial sectors, reflecting their commitment to delivering high-quality solutions. GHG Corporation prides itself on its diversity, technical achievements, and dedication to customer satisfaction.
Company Leadership LA
DB
FB